GlassScriptPhysician profile
Robert L Zanni
NPI 1982669529
$32,386.54
in general payments reported to CMS, 2019-2025
20 companies · $418 in 2025
The $418 reported for 2025 was more than what 76% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $5,218 · 2021: $323 · 2022: $293 · 2023: $4,146 · 2024: $241 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,060 · Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,060.00 |
| Food and Beverage | $746.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $26,628.24 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $4,322.74 | 2019-2025 | Trikafta |
| Aimmune Therapeutics, INC. | $313.00 | 2024-2025 | Zenpep |
| Philips North America LLC | $198.74 | 2020-2025 | Vest Therapy Und |
| Abbvie INC. | $168.39 | 2019-2024 | Creon |
| Baxter Healthcare | $140.52 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Nestle Healthcare Nutrition INC. | $115.84 | 2021 | |
| Genzyme Corporation | $110.21 | 2019 | |
| Electromed, INC. | $79.52 | 2021-2023 | Smartvest |
| Medtronic, INC. | $72.00 | 2025 | In.Pact Admiral, Spiderfx, Nitrex |
| Viatris Specialty LLC | $58.72 | 2025 | Tobi Podhaler |
| Advanced Respiratory, INC | $37.83 | 2019-2021 | |
| Phenox INC. | $30.55 | 2022 | |
| Abbott Laboratories | $29.14 | 2023 | |
| Sobi, INC | $25.27 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covis Pharma Gmbh | $22.78 | 2021 | |
| Chiesi USA, INC. | $18.13 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.92 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Zanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.